CE Information – Updated Guidance on Managing C. difficile Infection

Updated Guidance on Managing C. difficile Infection

Release: 3/9/2022 Expiration: 3/9/2023

Target Audience

This activity is designed for an audience of physicians and nurses.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe the newest recommendations on preferred and alternative treatments for diarrhea and colitis due to Clostridioides difficile infection (CDI).

Criteria for Success 

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at JGoldman@akhcme.com

akh-logo-newCE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

JAP

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Credit being awarded: 0.5 ANCC contact hours

Commercial Support

There is no commercial support for this activity.

Disclosures
NAME
RELATIONSHIP 
  COMPANY
Stuart Johnson, MD (faculty)

Advisory Board Member

Developed Education Monograph

Acurx Pharmaceuticals, BioK-Plus

Ferring Pharmaceuticals
Dorothy Caputo, MA, BSN, RN, Senior Director of Continuing Education & Compliance
 N/A
  Nothing to disclose
AKH Inc Staff and Planners
 N/A
  Nothing to disclose
Physician’s Weekly Staff and Planners
 N/A
  Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Back to